Explore licensed vaccines, adverse event reporting data, and history for this disease.
Multi-Jurisdiction Regulatory Status
Official licensing, rolling submissions, or authorization status tracked across major health authorities.
| Regulatory Authority | Status & Details |
|---|---|
| US FDA | Approved / Authorized Date: 2024+mRESVIA approved for indicated adult groups; pipeline may include expanded indications — check current label |
| EMA (Europe) | Not Filed / Pre-submission |
| Health Canada | Not Filed / Pre-submission |
| TGA (Australia) | Not Filed / Pre-submission |
Scientific Profile & Documentation
- Platform Architecture
- mRNA
- Lead Developer
- Moderna
- Next Expected Milestone
- Label expansions / seasonal updates as disclosed; see licensed RSV page for post-licensure safety
- Analyst & Development Notes
- When a candidate is approved, the site loop closes to the licensed vaccine evidence page (rsv-vaccine.html).
- Primary Source Documentation
- FDA vaccines licensed for use in the United States →
Registered Clinical Trials & Studies
Direct registry links to active, completed, or pivotal registration studies across phases.
No primary ClinicalTrials.gov record linked directly. Study data tracked via regulatory submission filings and peer-reviewed releases.
Milestone Overview
-
Stage VerificationApproved / Licensed confirmed as of 2026-07-10.
-
Target MilestoneLabel expansions / seasonal updates as disclosed; see licensed RSV page for post-licensure safety
Vaccine Data Navigator Candidate Profile Registry:
This candidate profile is indexed across all clinical development levels (Preclinical through Phase 1–3, Regulatory Filing, and Licensure) from primary registry databases (ClinicalTrials.gov, WHO ICTRP, FDA CBER, EMA, Health Canada, TGA Australia). Data are updated continuously to track global biologic and vaccine pipelines.